• Research & Development

  PAH Patients See More Improvement with Higher, More Frequent Revatio Doses, Study Says

  Posted by Pulmonary Hypertension News Moderator on September 17, 2018 at 6:09 pm

  Read about results of a clinical trial showing that Revatio 20 mg three times a day is the most effective dose tested in improving PAH parameters.

  Learn more about these type of diet here.

  What are your thoughts on this news?

  replied 7 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply